Ardelyx, Inc. (NASDAQ:ARDX – Get Free Report) was the target of a large drop in short interest in the month of May. As of May 15th, there was short interest totalling 33,040,000 shares, a drop of 6.1% from the April 30th total of 35,170,000 shares. Based on an average daily trading volume, of 5,610,000 shares, […]
Shares of Ardelyx, Inc. (NASDAQ:ARDX – Get Free Report) have been assigned a consensus recommendation of “Buy” from the nine analysts that are presently covering the firm, Marketbeat Ratings reports. Eight research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 12-month […]
Wedbush reissued their outperform rating on shares of Ardelyx (NASDAQ:ARDX – Free Report) in a report published on Friday, Benzinga reports. The firm currently has a $15.00 price target on the biopharmaceutical company’s stock. A number of other brokerages have also weighed in on ARDX. Citigroup increased their target price on shares of Ardelyx from […]
Ardelyx (NASDAQ:ARDX – Get Free Report)‘s stock had its “outperform” rating reaffirmed by stock analysts at Wedbush in a research note issued to investors on Friday, Benzinga reports. They currently have a $15.00 price target on the biopharmaceutical company’s stock. Wedbush’s price target would indicate a potential upside of 122.22% from the company’s previous close. […]